Skip to main content
. 2021 Sep 2;15:1281. doi: 10.3332/ecancer.2021.1281

Table 2. Response and toxicity.

Characteristics Pazopanib (N = 24)
N (%)
Pazopanib dose (starting dose)
400 mg
600 mg
800 mg

9 (27)
14 (43)
10 (30)
Best response
PR
SD
Progression

9 (27)
14 (43)
7 (21)
Grade III/IV toxicities 9 (27)
Dose modification needed 4 (17)